Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6607-6616

  Poon, Dexter T K ^b   Wu, Jim ^b   Aldovini, Anna ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS PROTEIN;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA ANALYSIS; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS NUCLEOCAPSID;

EID: 0029817879     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6607-6616.1996     Document Type: Article

References (50)

1. Aldovini, A., and M. B. Feinberg. 1990. Transfection of molecularly cloned HIV genomes, p. 147-175. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, Inc., New York.
2. Aldovini, A., and R. A. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
3. Aldovini, A., and R. A. Young. 1994. Construction and analysis of HIV and SIV mutants, p. 3-17. In K. W. Adolph (ed.), Methods in molecular genetics, vol. 4. Molecular virology techniques, part A. Academic Press, Inc., San Diego, Calif.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. John Wiley & Sons, Inc., New York.
5. Berg, J. 1986. Potential metal-binding domains in nucleic acid binding proteins. Science 232:485-486.
6. Berkowitz, R. D., J. Luban, and S. P. Goff. 1993. Specific binding of human immunodeficiency virus type 1 Gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 67:7190-7200.
7. Berkowitz, R. D., A. Ohagen, S. Hoglund, and S. P. Goff. 1995. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric polyproteins during RNA packaging in vivo. J. Virol. 69:6445-6456.
8. Bowles, N. E., P. Damay, and P. F. Spahr. 1993. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67:623-631.
9. Campbell, S., and V. M. Vogt. 1995. Assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69:6487-6497.
10. Cunningham, B. C., and J. A. Wells. 1989. High resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244: 1081-1085.
11. Daniel, M. D., N. L. Letvin, N. W. King, P. M. Kannagi, P. K. Sehgal, R. D. Hunt, P. J. Kanki, M. Essex, and R. C. Desrosiers. 1985. Isolation of a T cell tropic HTLV-III-like retrovirus from macaques. Science 228:1201-1204.
12. Dannull, J., A. Surovoy, G. Jung, and K. Moelling. 1994. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13:1525-1533.
13. De Rocquigny, H., C. Gabus, A. Vincent, M. C. Fourinie-Zaluski, B. Roques, and J. L. Darlix. 1992. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. USA 89:6472-6476.
14. Dorfman, T., J. Luban, S. P. Goff, W. A. Haseltine, and H. G. Gottlinger. 1993. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67:6159-6169.
15. Embretson, J. E., and H. M. Temin. 1987. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 61:2675-2683.
16. Feinberg, M. B., R. F. Jarrett, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
17. Fisher, A. G., E, Collalti, E. Ratner, R. C. Gallo, and F. Wong-Staal. 1985. A molecular clone of HTLV-III with biological activity. Nature (London) 316:262-265.
18. Fu, W., and A. Rein. 1993. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67:5443-5449.
19. Gibbs, C. S., and M. J. Zoller. 1991. Rational scanning mutagenesis of a protein kinase identifies functional regions involved in the catalysis and substrate interactions. J. Biol. Chem. 266:8923-8931.
20. Gorelick, R. J., D. J. Chabot, D. E. Ott, T. D. Gagliardi, A. Rein, L. E. Henderson, and L. O. Arthur. 1996. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 70:2593-2597.
21. + ' -finger function in RNA packaging but produce replication defective virus particles, abstr. 390. In Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections. Infectious Diseases Society of America, Alexandria, Va.
22. Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
23. Gorelick, R. J., S. M. Nigida, J. R. Bess, L. O. Arthur, L. E. Henderson, and A. Rein. 1990. Noninfectious human immunodeficiency virus type mutants deficient in genomic RNA. J. Virol. 64:3207-3211.
24. Horton, R. M., S. N. Ho, J. K. Pullen, H. D. Hunt, Z. Cai, and L. R. Pease. 1993. Gene splicing by overlap extension. Methods Enzymol. 217:270-279.
25. Housset, V., H. De Rocquigny, B. P. Roques, and J. L. Darlix. 1993. Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity. J. Virol. 67: 2537-2545.
26. Karpel, R. L., L. E. Henderson, and S. Orolszlan. 1987. Interactions of retroviral structural proteins with single-stranded nucleic acids. J. Biol. Chem. 262:4961-4967.
27. Kaye, J. F., J. H. Richardson, and A. M. L. Lever. 1995. cic-acting sequences involved in human immunodeficiency virus type 1 RNA packaging. J. Virol. 69:6588-6592.
28. Khan, R., and P. Giedroc. 1992. Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 267:6689-6695.
29. Kojima, E., T. Shirasaka, B. D. Anderson, S. Chokekijchai, S. M. Steinberg, S. Broder, R. Yarchoan, and H. Mitsuya. 1995. Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infections receiving alternating or simultaneous zidovudine and didanosine therapy. J. Infect. Dis. 171: 1152-1158.
30. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head bacterial phage T4. Nature (London) 227:680-685.
31. Lapadat-Tapolsky, M., H. De Rocquigny, D. Van Gent, B. Roques, R. Plasterk, and J. L. Darlix. 1993. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21:831-839.
32. Lazinski, D., E. Grzadzielska, and A. Das. 1989. Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators require a conserved arginine-rich motif. Cell 59:207-221.
33. Linial, M., E. Medeiros, and W. S. Hayward. 1978. An avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell 15:1371-1381.
34. Luban, J., and S. P. Golf. 1991. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 Gag polyprotein. J. Virol. 65:3203-3212.
35. Maurer, B., H. Bannaret, G. Darai, and R. M. Flugel. 1988. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 62:1590-1597.
36. Neumann, M., J. Harrison, M. Saltarelli, E. Hadziyannis, V. Erfle, B. K. Felber, and G. N. Pavlakis. 1994. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res. Hum. Retroviruses 10:1531-1542.
37. Ottmann, M., C. Cabus, and J. L. Darlix. 1995. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 69:1778-1784.
38. Popovic, M., M. G. Sarngadharan, E. Read, and R. C. Gallo. 1984. Detection isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
39. Prats, A. C, L. Sarih, C. Gabus, S. Litvak, G. Keith, and J. L. Darlix. 1988. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 7:1777-1783.
40. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway, Jr., M. L. Pearson, J. A. Lautenberg, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313:277-284.
41. Rein, A. 1994. Retroviral RNA packaging: a review. Arch. Virol. Suppl. 9:513-522.
42. Rein, A., D. P. Harvin, J. Mirro, S. M. Ernst, and R. J. Gorelick. 1994. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. J. Virol. 68:6124-6129.
43. Schmalzbauer, E., B. Strack, J. Dannull, S. Guehmann, and K. Moelling. 1996. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro. J. Virol. 70:771-777.
44. Sheng, N., and S. Erickson-Viitanen. 1994. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. J. Virol. 68:6207-6214.
45. Travers, K., and P. J. Kanki. 1990. HIV antibody detection in serum, p. 3-14. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, Inc., New York.
46. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 180:1283-1293.
47. Tsuchihashi, Z., and P. O. Brown. 1994. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68:5863-5870.
48. Weiss, R., N. Teich, J. Coffin, and H. Temin. 1984. RNA tumor virus. Genetics of retroviruses. p. 649-783. Cold Spring Harbor Laboratory, Cold Springs Harbor, N.Y.
49. Wertman, K. F., D. G. Drubin, and D. Botstein. 1992. Systematic mutational analysis of the yeast ACT1 gene. Genetics 132:337-350.
50. Zhang, Y., and E. Barklis. 1995. Nucleocapsid protein effects in the specificity of retrovirus RNA encapsidation. J. Virol. 69:5716-5722.